You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 333 Impact of extent of cytoreductive surgery (CRS) on survival in epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at the american university of beirut (AUBMC)

Citation Tools

Article menu

Download PDFPDF

E-Poster viewings
Ovarian Cancer
IGCS19-0335
333 Impact of extent of cytoreductive surgery (CRS) on survival in epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at the american university of beirut (AUBMC)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Seoud M, El Housheimi A, Jaafar I, et al
333 Impact of extent of cytoreductive surgery (CRS) on survival in epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at the american university of beirut (AUBMC)
International Journal of Gynecologic Cancer 2019;29:A138.